Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 3
1990 3
1991 3
1992 3
1993 6
1994 2
1995 3
1996 3
1997 11
1998 7
1999 7
2000 7
2001 7
2002 8
2003 6
2004 16
2005 12
2006 9
2007 10
2008 19
2009 17
2010 20
2011 27
2012 25
2013 39
2014 47
2015 45
2016 42
2017 51
2018 61
2019 53
2020 61
2021 63
2022 73
2023 47

Text availability

Article attribute

Article type

Publication date

Search Results

729 results

Results by year

Filters applied: . Clear all
Page 1
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Simonneau G, et al. Eur Respir J. 2019 Jan 24;53(1):1801913. doi: 10.1183/13993003.01913-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545968 Free PMC article. Review.
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) 25 mmHg at rest, measured by right heart catheterisation. ...However, thi …
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arb …
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
Maron BA, Abman SH, Elliott CG, Frantz RP, Hopper RK, Horn EM, Nicolls MR, Shlobin OA, Shah SJ, Kovacs G, Olschewski H, Rosenzweig EB. Maron BA, et al. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1472-1487. doi: 10.1164/rccm.202012-4317SO. Am J Respir Crit Care Med. 2021. PMID: 33861689 Free PMC article.
The diagnosis and management of pulmonary arterial hypertension (PAH) includes several advances, such as a broader recognition of extrapulmonary vascular organ system involvement, validated point-of-care clinical assessment tools, and focus on the early initiation o …
The diagnosis and management of pulmonary arterial hypertension (PAH) includes several advances, such as a broader recognition …
Risk stratification and medical therapy of pulmonary arterial hypertension.
Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Galiè N, et al. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545971 Free PMC article. Review.
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. ...
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of m …
Definitions and diagnosis of pulmonary hypertension.
Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB. Hoeper MM, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032. J Am Coll Cardiol. 2013. PMID: 24355641 Free article. Review.
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure 25 mm Hg at rest, measured during right heart catheterization. There is still insufficient evidence to add an exercise criterion to this definition. The term pulmonary arterial …
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure 25 mm Hg at rest, measured during right hear …
Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
Maron BA, Kovacs G, Vaidya A, Bhatt DL, Nishimura RA, Mak S, Guazzi M, Tedford RJ. Maron BA, et al. J Am Coll Cardiol. 2020 Dec 1;76(22):2671-2681. doi: 10.1016/j.jacc.2020.10.007. J Am Coll Cardiol. 2020. PMID: 33243385 Free PMC article. Review.
Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome, particularly in left heart disease (LHD) patients. Recent advances have clarified the mean pulmonary artery pressure (mPAP) range that is above normal and is associated wi …
Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome, particularly in left heart disease (LH …
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Omote K, Sorimachi H, Obokata M, Reddy YNV, Verbrugge FH, Omar M, DuBrock HM, Redfield MM, Borlaug BA. Omote K, et al. Eur Heart J. 2022 Sep 21;43(36):3417-3431. doi: 10.1093/eurheartj/ehac184. Eur Heart J. 2022. PMID: 35796488 Free PMC article.
AIMS: Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in left heart disease (LHD). ...Further study is required to identify novel treatments targeting the pulmonary vasculature in PH-LHD. …
AIMS: Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes …
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
McGlothlin DP, Granton J, Klepetko W, Beghetti M, Rosenzweig EB, Corris PA, Horn E, Kanwar MK, McRae K, Roman A, Tedford R, Badagliacca R, Bartolome S, Benza R, Caccamo M, Cogswell R, Dewachter C, Donahoe L, Fadel E, Farber HW, Feinstein J, Franco V, Frantz R, Gatzoulis M, Hwa Anne Goh C, Guazzi M, Hansmann G, Hastings S, Heerdt PM, Hemnes A, Herpain A, Hsu CH, Kerr K, Kolaitis NA, Kukreja J, Madani M, McCluskey S, McCulloch M, Moser B, Navaratnam M, Rådegran G, Reimer C, Savale L, Shlobin OA, Svetlichnaya J, Swetz K, Tashjian J, Thenappan T, Vizza CD, West S, Zuckerman W, Zuckermann A, De Marco T. McGlothlin DP, et al. J Heart Lung Transplant. 2022 Sep;41(9):1135-1194. doi: 10.1016/j.healun.2022.06.013. Epub 2022 Jun 23. J Heart Lung Transplant. 2022. PMID: 36123001
Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients undergoing surgery and anesthesia. This document represents the first international consensus statement for the perioperative management of patients with pulmonary hyperte …
Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients undergoing surgery and anesthesia. This d …
Pulmonary Hypertension in Left Heart Disease.
Reddy YNV, Borlaug BA. Reddy YNV, et al. Clin Chest Med. 2021 Mar;42(1):39-58. doi: 10.1016/j.ccm.2020.11.002. Clin Chest Med. 2021. PMID: 33541616 Review.
Pulmonary hypertension is common in left heart disease and is related most commonly to passive back transmission of elevated left atrial pressures. ...This review provides a contemporary appraisal of existing criteria to diagnose a precapillary component to pulmo …
Pulmonary hypertension is common in left heart disease and is related most commonly to passive back transmission of elevated l …
Frataxin deficiency promotes endothelial senescence in pulmonary hypertension.
Culley MK, Zhao J, Tai YY, Tang Y, Perk D, Negi V, Yu Q, Woodcock CC, Handen A, Speyer G, Kim S, Lai YC, Satoh T, Watson AM, Aaraj YA, Sembrat J, Rojas M, Goncharov D, Goncharova EA, Khan OF, Anderson DG, Dahlman JE, Gurkar AU, Lafyatis R, Fayyaz AU, Redfield MM, Gladwin MT, Rabinovitch M, Gu M, Bertero T, Chan SY. Culley MK, et al. J Clin Invest. 2021 Jun 1;131(11):e136459. doi: 10.1172/JCI136459. J Clin Invest. 2021. PMID: 33905372 Free PMC article.
The dynamic regulation of endothelial pathophenotypes in pulmonary hypertension (PH) remains undefined. Cellular senescence is linked to PH with intracardiac shunts; however, its regulation across PH subtypes is unknown. ...
The dynamic regulation of endothelial pathophenotypes in pulmonary hypertension (PH) remains undefined. Cellular senescence is …
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, Paulus WJ. Shah SJ, et al. Circulation. 2016 Jul 5;134(1):73-90. doi: 10.1161/CIRCULATIONAHA.116.021884. Circulation. 2016. PMID: 27358439 Free PMC article. Review.
In HFpEF, extracardiac comorbidities such as metabolic risk, arterial hypertension, and renal insufficiency drive left ventricular remodeling and dysfunction through systemic inflammation and coronary microvascular endothelial dysfunction. ...Systemic inflammation also aff …
In HFpEF, extracardiac comorbidities such as metabolic risk, arterial hypertension, and renal insufficiency drive left ventricular re …
729 results